Provided by Tiger Trade Technology Pte. Ltd.

MetaVia Inc

1.45
+0.00010.01%
Volume:37.60K
Turnover:56.03K
Market Cap:9.55M
PE:-0.39
High:1.52
Open:1.52
Low:1.45
Close:1.45
52wk High:14.85
52wk Low:0.9661
Shares:6.59M
Float Shares:4.81M
Volume Ratio:0.86
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7193
EPS(LYR):-7.3500
ROE:-175.68%
ROA:-58.82%
PB:1.40
PE(LYR):-0.20

Loading ...

MetaVia Names Sarah Browne Chief Medical Officer

Reuters
·
Yesterday

Metavia Appoints Seasoned Clinical Development Executive Sarah Browne, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Yesterday

Press Release: MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer

Dow Jones
·
Yesterday

Analyst Maintains Buy Rating on MetaVia (MTVA) with Unchanged $8 Price Target, Citing Strong Early Obesity Data for DA-1726

TIPRANKS
·
Sep 11

MetaVia Reports Preclinical Data Showing Obesity Drug DA-1726 Concentrates in Adipose Tissue

Reuters
·
Sep 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 19

MetaVia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

MetaVia Q2 EPS $(0.90) Misses $(0.82) Estimate

Benzinga Earnings
·
Aug 07

MetaVia Q2 FY26 Net Loss Widens to $5.3 Million

Reuters
·
Aug 07

MetaVia Inc Expected to Post a Loss of 82 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20

TIPRANKS
·
Jul 10

Metavia Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 10

Metavia Says All Active Patients Reach Highest Target Doses in Da-1726 Obesity Phase 1 Part 3 Study

Reuters
·
Jul 09

Metavia - All Patients Reach Highest Target Doses of 48 Mg and 64 Mg in Phase 1 Part 3

THOMSON REUTERS
·
Jul 09

Metavia - Topline Data from Phase 1 Part 3 Expected in Q4 2026

THOMSON REUTERS
·
Jul 09

Metavia Announces Completion of Dose Titration in Phase 1 Part 3 Study of Da-1726 for the Treatment of Obesity

THOMSON REUTERS
·
Jul 09

MetaVia CEO to join Life Sciences Virtual Investor Forum fireside chat on obesity, metabolic therapies

Reuters
·
Jun 17

Analysts Offer Insights on Healthcare Companies: MetaVia (MTVA) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Jun 09

BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors

Reuters
·
Jun 09

Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors

THOMSON REUTERS
·
Jun 09